Companion Animals

CatsDogs
The trademarks indicated by CAPITAL LETTERS in this publication are the property of, licensed to, promoted or distributed by Schering-Plough Corporation, its subsidiaries or related companies. As used in this publication, the terms “Schering-Plough” and the “company” refer collectively to Schering-Plough Corporation, the publicly held parent company, and its domestic and international subsidiaries, which are engaged in the discovery, development, manufacturing and marketing of pharmaceutical, animal health and consumer products worldwide.

Vaccines

Nobivac® Rabies

Active immunization against rabies. Nobivac Rabies is an inactivated vaccine that is registered for cats, dogs and certain other species.



Nobivac® DHP

Active immunization against the core canine diseases. Nobivac DHP provides dogs with immunity against distemper, hepatitis and parvovirus; it was the first vaccine in the world to be authorized for 3 year duration of immunity for these three components.


ProductDescription
RABDOMUN VACCINEA vaccine prepared from cell-culture-grown, chemically-inactivated rabies virus for the vaccination of healthy dogs, cats, cattle and sheep as an aid in the prevention of rabies.
RABDOMUN 1 VACCINEA vaccine prepared from cell-culture grown, chemically-inactivated rabies virus. For the annual vaccination of dogs and cats against rabies.
PANAGENA non-adjuvanted killed virus vaccine for the vaccination of healthy cats 8 to 9 weeks of age or older as an aid in the prevention of disease caused by feline panleukopenia virus.
NOBIVAC TRICATA live vaccine for the immunization of cats against feline viral rhinotracheitis, feline calicivirus and feline panleucopenia viral infections.
NOBIVAC RABIESAn inactivated vaccine for theimmunization of dogs, cats, cattle, sheep, goats, foxes, ferrets and horses, and in principle all healthy mammals against Rabies.
NOBIVAC PUPPY DPA live vaccine for the active immunization of young puppies against canine distemper and canine parvovirus disease.
NOBIVAC LEPTOA bivalent, inactivated vaccine for the immunization of dogs against leptospirosis caused by Leptospira canicola and Leptospira icterohaemorrhagiae.
NOBIVAC KCA live intranasal vaccine for the immunization of dogs against Bordetella bronchiseptica and Canine parainfluenza virus for periods of increased risk to reduce clinical signs induced by B. bronchiseptica and Canine parainfluenza virus and to reduce shedding of Canine parainfluenza virus.
NOBIVAC DHPPIA live vaccine for the immunization of dogs against canine distemper (CDV), canine contagious hepatitis caused by canine adenovirus type 1 (ICH), canine parvovirus disease (CPV) and respiratory disease caused by canine parainfluenza (CPi) and canine adenovirus type 2 (CAV2).
NOBIVAC DHPA live vaccine for the immunization of dogs against canine distemper (CDV), canine contagious hepatitis caused by canine adenovirus type 1 (ICH), canine parvovirus disease (CPV) and respiratory disease caused by canine adenovirus type 2 (CAV2).
NOBIVAC BBFor active immunisation of cats to reduce clinical signs of Bordetella bronchiseptica associated upper respiratory disease.
INTRA-TRAC 3/ADTA modified live Canine Adenovirus Type 2-Parainfluenza-Bordetella Bronchiseptica Vaccine. For the vaccination of dogs intranasally.
GALAXY PVA modified live virus vaccine containing a CPV Type 2b strain for the vaccination of healthy dogs, 6 weeks of age and older, as an aid in the prevention of disease caused by canine parvovirus.
GALAXY LYMEAn inactivated bacterin containing two isolates of Borrelia burgdorferi. This bacterin is for the vaccination of healthy dogs as an aid in the prevention of disease caused by Borrelia burgdorferi.
GALAXY DA2PPVL+CVA combination vaccine of a modified live virus vaccine (to prevent canine distemper, adenovirus type 2, hepatitis, parainfluenza, parvovirus) with inactivated Leptospira canicola and Leptospira icterohaemorrhagiae bacterin (to prevent leptospirosis) and killed virus vaccine containing feline enteric coronavirus (to prevent canine coronavirus ). For the vaccination of healthy dogs nine weeks of age or older.
GALAXY DA2PPVLA modified live virus vaccine which is combined with inactivated Leptospira canicola and L. icterohaemorrhagiae bacterin for the vaccination of healthy dogs, 6 weeks of age or older, as an aid in the prevention of disease caused by canine distemper virus, adenovirus type 1 (hepatitis), adenovirus type 2 (respiratory disease), canine parainfluenza virus, canine parvovirus, and leptospirosis.
GALAXY DA2PPV+CVA modified live virus vaccine for the vaccination of healthy dogs, 6 weeks of age and older, as an aid in the prevention of disease caused by canine distemper virus, adenovirus type 1 (hepatitis), adenovirus type 2 (respiratory disease), canine parainfluenza virus, and canine parvovirus.
GALAXY DA2PPVA modified live virus vaccine for the vaccination of healthy dogs, 6 weeks of age and older, as an aid in the prevention of disease caused by canine distemper virus, adenovirus type 1 (hepatitis) and adenovirus type 2 (respiratory disease), canine parainfluenza virus, and canine parvovirus.
GALAXY DModified live Canine Distemper virus vaccine. Contains Onderstepoort-type Canine Distemper strain. For the vaccination of healthy dogs 9 weeks and older.
GALAXY CVA killed virus vaccine containing feline enteric coronavirus. Recommended for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine coronavirus infection.
FVR C-P VACCINEA combination modified live and killed virus Feline Rhinotracheitis-Calici-Panleukopenia Vaccine vaccine. For vaccination of healthy cats 8 to 9 weeks of age or older as an aid in the prevention of disease caused by feline rhinotracheitis, feline calici and feline panleukopenia viruses.
FVR CA modified live virus vaccine for the vaccination of healthy cats 8 to 9 weeks of age or older as an aid in the prevention of disease caused by feline rhinotracheitis and calici viruses.
FEVAXYN FELVA tissue culture derived feline leukemia virus, Subgroups A and B vaccine. Used as an aid the prevention of lymphoid tumors caused by, and diseases associated with, feline leukemia virus (FeLV) infection.
ECLIPSE 4 + FELVA combination vaccine consisting of a modified live virus and chlamydia vaccine for the vaccination of healthy cats as an aid in the prevention of disease caused by feline rhinotracheitis, calici, and panleukopenia viruses and Chlamydia psittaci and a tissue culture derived feline leukemia virus, Subgroups A and B vaccine as an aid in the prevention of lymphoid tumors caused by, and diseases associated with, feline leukemia virus (FeLV) infection.
ECLIPSE 4A modified live virus and chlamydia vaccine for immunization of cats and kittens against feline rhinotracheitis, calici, panleukopenia viruses and chlamydia.
ECLIPSE 3 + FELVA combination vaccine consisting of a modified live virus vaccine to help prevent diseases caused by feline rhinotracheitis, calici, and panleukopenia viruses and a tissue culture derived feline leukemia virus, Subgroups A and B vaccine as an aid in the prevention of lymphoid tumors caused by, and diseases associated with, feline leukemia virus (FeLV) infection.
ECLIPSE 3A modified live virus vaccine for immunization of cats, 9 weeks of age or older, against feline rhinotracheitis, calici, and panleukopenia viruses.